TrialCirculation2016

Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome.

Leslie B Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.